RHJA
Rice Hall James & Associates Portfolio holdings
AUM
$1.86B
1-Year Return
33.9%
This Quarter Return
+15.94%
1 Year Return
+33.9%
3 Year Return
+119.1%
5 Year Return
+206.57%
10 Year Return
+613.71%
AUM
$1.73B
AUM Growth
+$152M
(+9.7%)
Cap. Flow
-$46.6M
Cap. Flow
% of AUM
-2.7%
Top 10 Holdings %
Top 10 Hldgs %
25.39%
Holding
270
New
10
Increased
28
Reduced
188
Closed
10
Top Buys
| 1 |
Establishment Labs
ESTA
|
$9.9M |
| 2 |
VRNA
Verona Pharma
VRNA
|
$8.81M |
| 3 |
Prestige Consumer Healthcare
PBH
|
$6.88M |
| 4 |
Addus HomeCare
ADUS
|
$3.75M |
| 5 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$3.42M |
Top Sells
| 1 |
BBBY
Bed Bath & Beyond, Inc.
BBBY
|
$16.4M |
| 2 |
Stride
LRN
|
$10.7M |
| 3 |
NXGN
NextGen Healthcare, Inc. Common Stock
NXGN
|
$9.14M |
| 4 |
Axos Financial
AX
|
$7.76M |
| 5 |
Cambium Networks
CMBM
|
$3.8M |
Sector Composition
| 1 | Healthcare | 30.1% |
| 2 | Technology | 23.66% |
| 3 | Industrials | 19.76% |
| 4 | Consumer Discretionary | 6.36% |
| 5 | Communication Services | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
eBay
EBAY
$42.3B
| $785K | 0.05% |
18,006
-850
| -5% | -$37.1K |
|
227
Dolby
DLB
$6.96B
| $781K | 0.05% |
9,060
-417
| -4% | -$35.9K |
|
228
IDEX
IEX
$12.3B
| $770K | 0.04% |
3,546
| – | – |
|
229
KBR
KBR
$6.35B
| $751K | 0.04% |
13,559
-28
| -0.2% | -$1.55K |
|
230
AbbVie
ABBV
$375B
| $749K | 0.04% |
4,836
| – | – |
|
231
Devon Energy
DVN
$22.6B
| $743K | 0.04% |
16,402
| – | – |
|
232
Ciena
CIEN
$16B
| $738K | 0.04% |
16,397
| – | – |
|
233
CDW
CDW
$21.6B
| $718K | 0.04% |
3,158
-9
| -0.3% | -$2.05K |
|
234
Teledyne Technologies
TDY
$25.7B
| $647K | 0.04% |
1,450
| – | – |
|
235
Glacier Bancorp
GBCI
$5.85B
| $643K | 0.04% |
15,565
-1,080
| -6% | -$44.6K |
|
236
Travere Therapeutics
TVTX
$1.82B
| $632K | 0.04% |
70,260
-8,102
| -10% | -$72.8K |
|
237
FMC
FMC
$4.6B
| $607K | 0.04% |
9,635
-1,581
| -14% | -$99.7K |
|
238
Y-mAbs Therapeutics
YMAB
$389M
| $583K | 0.03% |
85,513
-5,736
| -6% | -$39.1K |
|
239
Abbott
ABT
$231B
| $565K | 0.03% |
5,136
| – | – |
|
240
Alkermes
ALKS
$4.78B
| $563K | 0.03% |
+20,302
| New | +$563K |
|
241
Chevron
CVX
$320B
| $557K | 0.03% |
3,737
| – | – |
|
242
Crane NXT
CXT
$3.54B
| $552K | 0.03% |
9,710
| – | – |
|
243
Berkshire Hathaway Class A
BRK.A
$1.09T
| $543K | 0.03% |
1
| – | – |
|
244
Apple
AAPL
$3.53T
| $539K | 0.03% |
2,800
| – | – |
|
245
Inotiv
NOTV
$54.6M
| $517K | 0.03% |
140,749
-11,241
| -7% | -$41.3K |
|
246
scPharmaceuticals
SCPH
$299M
| $508K | 0.03% |
81,004
-6,067
| -7% | -$38K |
|
247
Jacobs Solutions
J
$17.1B
| $460K | 0.03% |
4,286
| – | – |
|
248
Sysco
SYY
$39.1B
| $406K | 0.02% |
5,552
| – | – |
|
249
Moody's
MCO
$89.5B
| $362K | 0.02% |
928
| – | – |
|
250
JPMorgan Chase
JPM
$835B
| $350K | 0.02% |
2,058
| – | – |
|